In comparison to patients with choline-based sRT, patients with PSMA PET/CT-based sRT had a significantly worse oncologic tumor status regarding iPSA, tumor stage, Gleason score, pathologic lymph nodes and percentage with postoperative PSA persistence. The gene discussed is FOLH1; the disease is neoplasm.